{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:55:49Z","timestamp":1770332149288,"version":"3.49.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The ongoing coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic. Currently, supportive care measures remain the standard of care for severe and critical COVID-19 patients, such as ventilation oxygenation, fluid management and blood purification. In this study, we aimed to evaluate the effects of early blood purification therapy upon severe and\/or critical COVID-19 patients.<\/jats:p><jats:p><jats:bold>Patients and Methods:<\/jats:bold> From January 31, 2020 to March 1, 2020, a total 5 patients with COVID-19 (3 critical type cases and 2 severe type cases) received early blood purification treatment in the intensive care unit (ICU) of Affiliated Hospital of Zunyi Medical University. Clinical indexes, including oxygen concentration, blood gas analysis, oxygenation index, and laboratory test as well as disease scores were recorded and analyzed before and after the treatment with blood purification.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among the 5 patients, 4 were males ranging from 35 to 80 year old (Mean age = 63 \u00b1 17.87). All cases with characteristics of OI &amp;lt;300 mm Hg, decline in lymphocyte (LYMPH)%, boost in lactate dehydrogenase (LDH), troponin T (TNT), B-type brain natriuretic peptide (BNP), interleukin-6 (IL-6) and interferon-alpha (IFN-a), three with high flow nasal cannula (HFNC), two with non-invasive ventilation (NIV) and acute kidney injury (AKI), and one with shock and IV. Blood purification therapy significantly decreased the serum levels of inflammatory cytokine, ameliorated the concomitant symptoms and complications. Finally, one case was discharged from the hospital, 4 cases were transferred to the general ward, and all the 5 cases survived.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Continuous blood purification therapy held promising prospects for alleviating the deteriorative progression of severe and critical types of COVID-19 in the early stage, together with ameliorating the accumulation of inflammatory cytokine and the concomitant symptoms and complications by efficacious immunoadsorption.<\/jats:p><jats:p><jats:bold>Trial Registration:<\/jats:bold><jats:ext-link>www.chictr.org.cn<\/jats:ext-link>, Identifier (ChiCTR2000031930).<\/jats:p>","DOI":"10.3389\/fpubh.2021.741125","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T04:53:18Z","timestamp":1637124798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Hongjun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leisheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3389\/fimmu.2020.00924","article-title":"Dendritic cells and their role in immunotherapy","volume":"11","author":"Gardner","year":"2020","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-020-1577-2","article-title":"Multifaceted characterization of the signatures and efficacy of mesenchymal stem\/stromal cells in acquired aplastic anemia","volume":"11","author":"Huo","year":"2020","journal-title":"Stem Cell Res Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(20)30084-4","article-title":"COVID-19 and the liver: little cause for concern","volume":"5","author":"Bangash","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2020.1735227","article-title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","author":"Dhama","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fimmu.2020.01512","article-title":"Flattening the COVID-19 curve with natural killer cell based immunotherapies","volume":"11","author":"Market","year":"2020","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-020-00286-5","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial","volume":"5","author":"Meng","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"102855","DOI":"10.1016\/j.transci.2020.102855","article-title":"Extracorporeal blood purification treatment options for COVID-19: the role of immunoadsorption","volume":"59","author":"Yigenoglu","year":"2020","journal-title":"Transfus Apher Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000509738","article-title":"The combined use of tocilizumab and hemoadsorption in a patient with SARS-COV-2-19-associated pneumonia: a case report","volume":"144","author":"Berlot","year":"2020","journal-title":"Nephron."},{"key":"B15","doi-asserted-by":"publisher","first-page":"108408","DOI":"10.1016\/j.clim.2020.108408","article-title":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19","volume":"214","author":"Ma","year":"2020","journal-title":"Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/aor.14024","article-title":"Blood purification with cytosorb in critically ill COVID-19 patients: a case series of 26 patients","volume":"45","author":"Nassiri","year":"2021","journal-title":"Artif Organs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/cr.2015.118","article-title":"MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling","volume":"25","author":"Wu","year":"2015","journal-title":"Cell Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13287-021-02444-0","article-title":"Bone marrow-derived mesenchymal stem\/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13287-018-0926-x","article-title":"Thrombopoietin knock-in augments platelet generation from human embryonic stem cells","volume":"9","author":"Zhang","year":"2018","journal-title":"Stem Cell Res Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.stemcr.2018.06.019","article-title":"MSX2 initiates and accelerates mesenchymal stem\/stromal cell specification of hPSCs by regulating TWIST1 and PRAME","volume":"11","author":"Zhang","year":"2018","journal-title":"Stem Cell Reports."},{"key":"B21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bcmd.2019.02.003","article-title":"Decitabine improves platelet recovery by down-regulating IL-8 level in MDS\/AML patients with thrombocytopenia","volume":"76","author":"Zhang","year":"2019","journal-title":"Blood Cells Mol Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12015-020-09973-w","article-title":"Mesenchymal stem cell therapy for COVID-19: present or future","volume":"16","author":"Golchin","year":"2020","journal-title":"Stem Cell Rev Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J Pharm Anal."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000499355","article-title":"Sepsis management with a blood purification membrane: European experience","volume":"47","author":"Pickkers","year":"2019","journal-title":"Blood Purif."},{"key":"B26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.23736\/S0375-9393.20.15124-1","article-title":"Extracorporeal immune modulation in COVID-19 induced immune dysfunction and secondary infections: the role of oXiris(R) membrane","volume":"87","author":"Cascarano","year":"2021","journal-title":"Minerva Anestesiol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13730","article-title":"Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients","author":"Premuzic","year":"2021","journal-title":"Ther Apher Dial"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000515627","article-title":"Extracorporeal blood purification in moderate and severe COVID-19 patients: a prospective cohort study","author":"Rosalia","year":"2021","journal-title":"Blood Purif."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/aor.13786","article-title":"The absorbing filter oxiris in severe coronavirus disease 2019 patients: a case series","volume":"44","author":"Zhang","year":"2020","journal-title":"Artif Organs."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/aor.14016","article-title":"High-volume hemofiltration reduces short-term mortality with no influence on the incidence of MODS, hospital stay, and hospitalization cost in patients with severe-acute pancreatitis: a meta-analysis","author":"Huang","year":"2021","journal-title":"Artif Organs"},{"key":"B31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/aor.13884","article-title":"Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients","volume":"45","author":"Dai","year":"2021","journal-title":"Artif Organs."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X16666210712212421","article-title":"Visualized analyses of investigations upon mesenchymal stem\/stromal cell-based cytotherapy and underlying mechanisms for COVID-19 associated ARDS","author":"Aitong","year":"2021","journal-title":"Curr Stem Cell Res Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia","volume":"395","author":"Shang","year":"2020","journal-title":"Lancet."},{"key":"B34","first-page":"1770","article-title":"Natural killer cells: of-the-shelf cytotherapy for cancer immunosurveillance","volume":"11","author":"Zhang","year":"2021","journal-title":"Am J Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.4252\/wjsc.v13.i8.1058","article-title":"Therapeutic prospects of mesenchymal stem\/stromal cells in COVID-19 associated pulmonary diseases: from bench to bedside","volume":"13","author":"Zhang","year":"2021","journal-title":"World J Stem Cells."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.741125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T04:53:31Z","timestamp":1637124811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.741125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":35,"alternative-id":["10.3389\/fpubh.2021.741125"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2021.741125","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"article-number":"741125"}}